Marion Odence-Ford - 11 Feb 2022 Form 4 Insider Report for OptimizeRx Corp (OPRX)

Role: General Counsel and CCO
Signature: /s/ Marion Odence-Ford
Issuer symbol: OPRX
Transactions as of: 11 Feb 2022
Net transactions value: $0
Form type: 4
Filing time: 15 Feb 2022, 15:45:27 UTC
Previous filing: 10 Nov 2021
Next filing: 03 Mar 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	OPRX	Common Stock	Options Exercise		+4,000			4,000	11 Feb 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	OPRX	Restricted Stock Units	Options Exercise	$0	-4,000	-20%	$0.000000	16,000	11 Feb 2022	Common Stock	4,000		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted stock units convert into common stock on a one-for-one basis.
F2	On February 11, 2021, the reporting person was granted 20,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date

Remarks:

The filing of this Statement shall not be construed as an admission (a) that the person filing this Statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this Statement, or (b) that this Statement is legally required to be filed by such person.